newsfilter
← Latest News
GlobeNewswire·

Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference

  • Praxis Precision Medicines will present a corporate overview at the Goldman Sachs 47th Annual Global Healthcare Conference 2026.
  • The event is scheduled for Monday, June 8, 2026, at 8:00am ET at the Loews Miami Beach Hotel in Miami, FL.
  • A live webcast of the presentation will be available via a provided link.
  • An event replay will be hosted on Praxis' "Events and Presentations" website for approximately 180 days.
  • Praxis is a CNS precision neuroscience biopharmaceutical company translating genetic epilepsy insights into therapies for neuronal excitation-inhibition imbalance.
  • The company utilizes its proprietary Cerebrum™ small molecule platform Solidus™ ASO platform to develop treatments for rare prevalent neurological disorders.
  • Praxis maintains a diversified multimodal CNS portfolio with four late-stage product candidates across movement disorders epilepsy.